Very interesting. The antibiotic in question is lolamicin.
I've been on the lookout for an antibiotic which can selectively kill gram-negative bacteria, but does not harm gram-positive bacteria.
Lolamicin appears to do just that.
Selective targeting of gram negatives could be beneficial for health, as most of the clinically harmful bacteria are gram-negative, whereas most probiotics are gram positive.
Harmful gram negatives include: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, Helicobacter pylori, Enterobacter cloacae, Acinetobacter baumannii, Serratia marcescens, Moraxella catarrhalis, Legionella pneumophila.
There are a few harmful gram positive bacteria, such as: Staphylococcus and Streptococcus.
Beneficial gut bacteria like Bacteroides are gram negatives.
Streptomycin and other aminoglycoside antibiotics kill gram negatives but not gram positives; unfortunately these aminoglycoside antibiotics can cause permanent ear and hearing damage (ototoxic), so they are only used as a last resort.
Aztreonam is another antibiotic which selectively targets gram negatives. This is normally given by intravenous injection, as it is not orally absorbed. But I wonder if taken orally, would it then target the gut microbiome. Aztreonam is usually well-tolerated.